Charlotte Lemech
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Immunotherapy Targeting of Cytomegalovirus Antigens in Glioblastoma (NCT06132438) | Charlotte Lemech | 2023-11-01 |
Track Charlotte Lemech automatically
Every clearance here is in the API, with alerts when new ones post.